Inflammation in Diabetic Nephropathy

Inflammation in Diabetic Nephropathy

Diabetic nephropathy is the leading cause of end-stage kidney disease worldwide but current treatments remain suboptimal. This review examines the evidence for inflammation in the development and progression of diabetic nephropathy in both experimental and human diabetes, and provides an update on r...

Disgrifiad llawn

Wedi'i Gadw mewn:

Manylion Llyfryddiaeth
Prif Awduron:	Andy K.H. Lim, Greg H. Tesch
Fformat:	Revisão
Iaith:	Saesneg
Cyhoeddwyd:	2012
Mynediad Ar-lein:	https://doi.org/10.1155/2012/146154 https://downloads.hindawi.com/journals/mi/2012/146154.pdf
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg

Inflammation in Diabetic Nephropathy
gan: Lim, Andy K. H., et al.
Cyhoeddwyd: (2012)

Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice
gan: Andy K.H. Lim, et al.
Cyhoeddwyd: (2009)

Diabetic nephropathy &ndash; complications and treatment
gan: Andy K.H. Lim
Cyhoeddwyd: (2014)

Diabetic nephropathy – complications and treatment
gan: Lim, Andy KH
Cyhoeddwyd: (2014)

Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis
gan: F. Y. Chow, et al.
Cyhoeddwyd: (2004)

Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury
gan: Andy K.H. Lim, et al.
Cyhoeddwyd: (2010)

Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury
gan: Fiona Chow, et al.
Cyhoeddwyd: (2003)

Diabetic nephropathy and inflammation
gan: Montserrat B. Duran-Salgado
Cyhoeddwyd: (2014)

Diabetic nephropathy and inflammation
gan: Duran-Salgado, Montserrat B, et al.
Cyhoeddwyd: (2014)

ASK1 Inhibitor Halts Progression of Diabetic Nephropathy in <i>Nos3</i>-Deficient Mice
gan: Greg H. Tesch, et al.
Cyhoeddwyd: (2015)

Epigenetics and Inflammation in Diabetic Nephropathy
gan: Baoyi Shao, et al.
Cyhoeddwyd: (2021)

Intercellular Adhesion Molecule-1 Deficiency Is Protective against Nephropathy in Type 2 Diabetic db/db Mice
gan: Fiona YF CHOW, et al.
Cyhoeddwyd: (2005)

Epigenetics and Inflammation in Diabetic Nephropathy
gan: Shao, Bao-Yi, et al.
Cyhoeddwyd: (2021)

Role of MKK3–p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db/db mice
gan: Andy K.H. Lim, et al.
Cyhoeddwyd: (2008)

Diabetes, Inflammation, Proinflammatory Cytokines, and Diabetic Nephropathy
gan: Juan F. Navarro‐González, et al.
Cyhoeddwyd: (2006)

Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy
gan: L Adhikary, et al.
Cyhoeddwyd: (2004)

Diabetes, Inflammation, Proinflammatory Cytokines, and Diabetic Nephropathy
gan: Navarro, Juan F., et al.
Cyhoeddwyd: (2006)

Immune Cells and Inflammation in Diabetic Nephropathy
gan: Zihan Zheng, et al.
Cyhoeddwyd: (2015)

Diabetic Nephropathy: Proteinuria, Inflammation, and Fibrosis
gan: Shirong Zheng, et al.
Cyhoeddwyd: (2016)

Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy
gan: Desirée Luis-Rodríguez
Cyhoeddwyd: (2012)

Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols
gan: Qi Jin, et al.
Cyhoeddwyd: (2023)

Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy
gan: Luis-Rodríguez, Desirée, et al.
Cyhoeddwyd: (2012)

Epac activation ameliorates tubulointerstitial inflammation in diabetic nephropathy
gan: Yang, Wen-xia, et al.
Cyhoeddwyd: (2021)

Diabetic Nephropathy
gan: Lionel H. Opie, et al.
Cyhoeddwyd: (2002)

Cellular Basis of Diabetic Nephropathy
gan: Maria Luiza Caramori, et al.
Cyhoeddwyd: (2002)

Prognosis in diabetic nephropathy.
gan: H.‐H. Parving, et al.
Cyhoeddwyd: (1989)

Diabetic nephropathy
gan: Zelmanovitz, Themis, et al.
Cyhoeddwyd: (2009)

Prognosis in diabetic nephropathy.
gan: Parving, H. H., et al.
Cyhoeddwyd: (1989)

Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis
gan: Keizo Kanasaki, et al.
Cyhoeddwyd: (2013)

Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy
gan: Sandra Rayego‐Mateos, et al.
Cyhoeddwyd: (2020)

Inflammation and Immunity Pathways Regulate Genetic Susceptibility to Diabetic Nephropathy
gan: Susan B. Gurley, et al.
Cyhoeddwyd: (2018)

Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis
gan: Kanasaki, Keizo, et al.
Cyhoeddwyd: (2013)

Inflammation and Immunity Pathways Regulate Genetic Susceptibility to Diabetic Nephropathy
gan: Gurley, Susan B., et al.
Cyhoeddwyd: (2018)

Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy
gan: Rayego-Mateos, Sandra, et al.
Cyhoeddwyd: (2020)

Abnormal liver function tests associated with severe rhabdomyolysis
gan: Andy K.H. Lim
Cyhoeddwyd: (2020)

Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients
gan: Markku Saraheimo, et al.
Cyhoeddwyd: (2003)

Inflammation and Progressive Nephropathy in Type 1 Diabetes in the Diabetes Control and Complications Trial
gan: Julie Lin, et al.
Cyhoeddwyd: (2008)

Toll-Like Receptor 4 Promotes Tubular Inflammation in Diabetic Nephropathy
gan: Miao Lin, et al.
Cyhoeddwyd: (2011)

Inflammation and Progressive Nephropathy in Type 1 Diabetes in the Diabetes Control and Complications Trial
gan: Lin, Julie, et al.
Cyhoeddwyd: (2008)

Silent diabetic nephropathy
gan: Samar M. Said, et al.
Cyhoeddwyd: (2016)